{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:13:34Z","timestamp":1778044414428,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5175,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1046\/j.0022-202x.2001.01465.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:59:55Z","timestamp":1047430795000},"page":"858-863","source":"Crossref","is-referenced-by-count":56,"title":["Virologic and Immunologic Parameters that Predict Clinical Response of AIDS-Associated Kaposi's Sarcoma to Highly Active Antiretroviral Therapy"],"prefix":"10.1016","volume":"117","author":[{"given":"C.","family":"Pellet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gauvill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hurault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Agbalika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lascoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ponscarme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.190.4.567","article-title":"Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients","volume":"190","author":"Babcock","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0015","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/00002030-200009080-00004","article-title":"Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy","volume":"14","author":"Boivin","year":"2000","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0020","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","article-title":"Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma","volume":"13","author":"Bower","year":"1999","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0025","first-page":"44","article-title":"Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"22","author":"Cattelan","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/00002030-199817000-00013","article-title":"Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine","volume":"12","author":"Chene","year":"1998","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2133.1999.02818.x","article-title":"The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma","volume":"140","author":"Dupin","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0040","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":"Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodeficience humaine [In Process Citation]","volume":"14","author":"Dupont","year":"2000","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/JVI.50.1.248-254.1984","article-title":"Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis","volume":"50","author":"Gardella","year":"1984","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1523-1747.1999.00733.x","article-title":"Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma","volume":"113","author":"Henry","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00002030-199704000-00017","article-title":"Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group","volume":"11","author":"Hermans","year":"1997","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/mp.50.2.96","article-title":"HHV8 and Kaposi's sarcoma: a time cohort study [published erratum appears in Mol Pathol 5: 167 1997]","volume":"50","author":"Kennedy","year":"1997","journal-title":"Mol Pathol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0070","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0075","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/JCM.38.4.1404-1408.2000","article-title":"Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay","volume":"38","author":"Lallemand","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0080","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199807000-00002","article-title":"Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma","volume":"12","author":"Lebbe","year":"1998","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0085","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"Jama"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0090","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi's sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-0934(96)02139-8","article-title":"Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8","volume":"64","author":"Lock","year":"1997","journal-title":"J Virol Meth"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0105","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.1994.12.9.1910","article-title":"Improved survival for patients with AIDS-related Kaposi's sarcoma","volume":"12","author":"Miles","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","article-title":"Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study","volume":"130","author":"Miller","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0115","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00002030-200005260-00002","article-title":"Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx\/KS Spanish Study Group","volume":"14","author":"Nunez","year":"2000","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-126-12-199706150-00002","article-title":"Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS","volume":"126","author":"O'Brien","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0125","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","article-title":"High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0130","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1128\/JVI.73.7.6136-6140.1999","article-title":"Identification of human herpesvirus 8-specific cytotoxic T-cell responses","volume":"73","author":"Osman","year":"1999","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0135","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1128\/JVI.72.6.5182-5188.1998","article-title":"Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells","volume":"72","author":"Renne","year":"1998","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0140","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/00002030-199818000-00018","article-title":"Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma","volume":"12","author":"Renwick","year":"1998","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-200007280-00021","article-title":"Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study","volume":"14","author":"Rezza","year":"2000","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0150","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1099\/0022-1317-79-7-1573","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8)","volume":"79","author":"Schulz","year":"1998","journal-title":"J General Virol"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0155","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00002030-200008180-00001","article-title":"Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy","volume":"14","author":"Tirelli","year":"2000","journal-title":"Aids"},{"key":"10.1046\/j.0022-202x.2001.01465.x_bb0160","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.73.12.10329-10338.1999","article-title":"Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus","volume":"73","author":"Varthakavi","year":"1999","journal-title":"J Virol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15413879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T22:22:31Z","timestamp":1580941351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15413879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0022202X15413879"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01465.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}